Table of Contents 1 Parecoxib Sodium (CAS 198470-85-8) Market Overview 1.1 Product Overview and Scope of Parecoxib Sodium (CAS 198470-85-8) 1.2 Parecoxib Sodium (CAS 198470-85-8) Segment by Type 1.2.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Original Drug 1.2.3 Generic Drug 1.3 Parecoxib Sodium (CAS 198470-85-8) Segment by Application 1.3.1 Parecoxib Sodium (CAS 198470-85-8) Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Global Parecoxib Sodium (CAS 198470-85-8) Market Size Estimates and Forecasts 1.4.1 Global Parecoxib Sodium (CAS 198470-85-8) Revenue 2015-2026 1.4.2 Global Parecoxib Sodium (CAS 198470-85-8) Sales 2015-2026 1.4.3 Parecoxib Sodium (CAS 198470-85-8) Market Size by Region: 2020 Versus 2026 2 Global Parecoxib Sodium (CAS 198470-85-8) Market Competition by Manufacturers 2.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Manufacturers (2015-2020) 2.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Manufacturers (2015-2020) 2.3 Global Parecoxib Sodium (CAS 198470-85-8) Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Parecoxib Sodium (CAS 198470-85-8) Manufacturing Sites, Area Served, Product Type 2.5 Parecoxib Sodium (CAS 198470-85-8) Market Competitive Situation and Trends 2.5.1 Parecoxib Sodium (CAS 198470-85-8) Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Parecoxib Sodium (CAS 198470-85-8) Players (Opinion Leaders) 3 Parecoxib Sodium (CAS 198470-85-8) Retrospective Market Scenario by Region 3.1 Global Parecoxib Sodium (CAS 198470-85-8) Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Parecoxib Sodium (CAS 198470-85-8) Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures by Country 3.3.1 North America Parecoxib Sodium (CAS 198470-85-8) Sales by Country 3.3.2 North America Parecoxib Sodium (CAS 198470-85-8) Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures by Country 3.4.1 Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Country 3.4.2 Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures by Region 3.5.1 Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Region 3.5.2 Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures by Country 3.6.1 Latin America Parecoxib Sodium (CAS 198470-85-8) Sales by Country 3.6.2 Latin America Parecoxib Sodium (CAS 198470-85-8) Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures by Country 3.7.1 Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Country 3.7.2 Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Parecoxib Sodium (CAS 198470-85-8) Historic Market Analysis by Type 4.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020) 4.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Type (2015-2020) 4.3 Global Parecoxib Sodium (CAS 198470-85-8) Price Market Share by Type (2015-2020) 4.4 Global Parecoxib Sodium (CAS 198470-85-8) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Parecoxib Sodium (CAS 198470-85-8) Historic Market Analysis by Application 5.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020) 5.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Application (2015-2020) 5.3 Global Parecoxib Sodium (CAS 198470-85-8) Price by Application (2015-2020) 6 Company Profiles and Key Figures in Parecoxib Sodium (CAS 198470-85-8) Business 6.1 Pfizer 6.1.1 Corporation Information 6.1.2 Pfizer Description, Business Overview and Total Revenue 6.1.3 Pfizer Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Pfizer Products Offered 6.1.5 Pfizer Recent Development 6.2 Sailong Pharma 6.2.1 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Production Sites and Area Served 6.2.2 Sailong Pharma Description, Business Overview and Total Revenue 6.2.3 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Sailong Pharma Products Offered 6.2.5 Sailong Pharma Recent Development 6.3 Chiarai Tianqing 6.3.1 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Production Sites and Area Served 6.3.2 Chiarai Tianqing Description, Business Overview and Total Revenue 6.3.3 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Chiarai Tianqing Products Offered 6.3.5 Chiarai Tianqing Recent Development 6.4 Qilu Pharma 6.4.1 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Production Sites and Area Served 6.4.2 Qilu Pharma Description, Business Overview and Total Revenue 6.4.3 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Qilu Pharma Products Offered 6.4.5 Qilu Pharma Recent Development 6.5 Kelun Pharma 6.5.1 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Production Sites and Area Served 6.5.2 Kelun Pharma Description, Business Overview and Total Revenue 6.5.3 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Kelun Pharma Products Offered 6.5.5 Kelun Pharma Recent Development 7 Parecoxib Sodium (CAS 198470-85-8) Manufacturing Cost Analysis 7.1 Parecoxib Sodium (CAS 198470-85-8) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Parecoxib Sodium (CAS 198470-85-8) 7.4 Parecoxib Sodium (CAS 198470-85-8) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Parecoxib Sodium (CAS 198470-85-8) Distributors List 8.3 Parecoxib Sodium (CAS 198470-85-8) Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Parecoxib Sodium (CAS 198470-85-8) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Parecoxib Sodium (CAS 198470-85-8) by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Parecoxib Sodium (CAS 198470-85-8) by Type (2021-2026) 10.2 Parecoxib Sodium (CAS 198470-85-8) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Parecoxib Sodium (CAS 198470-85-8) by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Parecoxib Sodium (CAS 198470-85-8) by Application (2021-2026) 10.3 Parecoxib Sodium (CAS 198470-85-8) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Parecoxib Sodium (CAS 198470-85-8) by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Parecoxib Sodium (CAS 198470-85-8) by Region (2021-2026) 10.4 North America Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2021-2026) 10.5 Europe Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2021-2026) 10.6 Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2021-2026) 10.7 Latin America Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2021-2026) 10.8 Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Growth Rate Comparison by Type (2015-2026) Table 2. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Comparison by Application: 2020 VS 2026 Table 3. Global Parecoxib Sodium (CAS 198470-85-8) Market Size by Type (Kg) (US$ Million) (2020 VS 2026) Table 4. Global Key Parecoxib Sodium (CAS 198470-85-8) Manufacturers Covered in This Study Table 5. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Manufacturers (2015-2020) Table 6. Global Parecoxib Sodium (CAS 198470-85-8) Sales Share by Manufacturers (2015-2020) Table 7. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Parecoxib Sodium (CAS 198470-85-8) Average Price (USD/Kg) of Key Manufacturers (2015-2020) Table 10. Manufacturers Parecoxib Sodium (CAS 198470-85-8) Sales Sites and Area Served Table 11. Manufacturers Parecoxib Sodium (CAS 198470-85-8) Product Types Table 12. Global Parecoxib Sodium (CAS 198470-85-8) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Parecoxib Sodium (CAS 198470-85-8) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parecoxib Sodium (CAS 198470-85-8) as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Parecoxib Sodium (CAS 198470-85-8) Players Table 16. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Region (2015-2020) Table 17. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2015-2020) Table 18. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) by Region (2015-2020) Table 19. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region (2015-2020) Table 20. North America Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2015-2020) (Kg) Table 21. North America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2015-2020) Table 22. North America Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2015-2020) (US$ Million) Table 23. North America Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2015-2020) Table 24. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2015-2020) (Kg) Table 25. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2015-2020) Table 26. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Region (2015-2020) (Kg) Table 29. Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region (2015-2020) Table 32. Latin America Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2015-2020) (Kg) Table 33. Latin America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2015-2020) Table 34. Latin America Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2015-2020) (Kg) Table 37. Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2015-2020) Table 40. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Type (2015-2020) Table 41. Global Parecoxib Sodium (CAS 198470-85-8) Sales Share by Type (2015-2020) Table 42. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) by Type (2015-2020) Table 43. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Type (2015-2020) Table 44. Global Parecoxib Sodium (CAS 198470-85-8) Price (USD/Kg) by Type (2015-2020) Table 45. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Application (2015-2020) Table 46. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020) Table 47. Global Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Parecoxib Sodium (CAS 198470-85-8) Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Corporation Information Table 54. Sailong Pharma Corporation Information Table 55. Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 56. Sailong Pharma Main Product Table 57. Sailong Pharma Recent Development Table 58. Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Corporation Information Table 59. Chiarai Tianqing Corporation Information Table 60. Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 61. Chiarai Tianqing Main Product Table 62. Chiarai Tianqing Recent Development Table 63. Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Corporation Information Table 64. Qilu Pharma Corporation Information Table 65. Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 66. Qilu Pharma Main Product Table 67. Qilu Pharma Recent Development Table 68. Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Corporation Information Table 69. Kelun Pharma Corporation Information Table 70. Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 71. Kelun Pharma Main Product Table 72. Kelun Pharma Recent Development Table 73. Sales Base and Market Concentration Rate of Raw Material Table 74. Key Suppliers of Raw Materials Table 75. Parecoxib Sodium (CAS 198470-85-8) Distributors List Table 76. Parecoxib Sodium (CAS 198470-85-8) Customers List Table 77. Market Key Trends Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 79. Key Challenges Table 80. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Forecast by Type (2021-2026) Table 81. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share Forecast by Type (2021-2026) Table 82. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) Forecast by Type (2021-2026) Table 83. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 84. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Forecast by Application (2021-2026) Table 85. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) Forecast by Application (2021-2026) Table 86. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Forecast by Region (2021-2026) Table 87. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share Forecast by Region (2021-2026) Table 88. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Region (2021-2026) (US$ Million) Table 89. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share Forecast by Region (2021-2026) Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Parecoxib Sodium (CAS 198470-85-8) Figure 2. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type: 2020 VS 2026 Figure 3. Original Drug Product Picture Figure 4. Generic Drug Product Picture Figure 5. Global Parecoxib Sodium (CAS 198470-85-8) Consumption Market Share by Application: 2020 VS 2026 Figure 6. Hospital Pharmacies Figure 7. Retail Pharmacies Figure 8. Online Pharmacies Figure 9. Global Parecoxib Sodium (CAS 198470-85-8) Market Size 2015-2026 (US$ Million) Figure 10. Global Parecoxib Sodium (CAS 198470-85-8) Sales Capacity (Kg) (2015-2026) Figure 11. Global Parecoxib Sodium (CAS 198470-85-8) Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Parecoxib Sodium (CAS 198470-85-8) Sales Share by Manufacturers in 2020 Figure 13. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Parecoxib Sodium (CAS 198470-85-8) Revenue in 2019 Figure 15. Parecoxib Sodium (CAS 198470-85-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2015-2020) Figure 17. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region in 2019 Figure 18. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region (2015-2020) Figure 19. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region in 2019 Figure 20. North America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country in 2019 Figure 21. North America Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country in 2019 Figure 22. U.S. Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 23. U.S. Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 25. Canada Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country in 2019 Figure 27. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country in 2019 Figure 28. Germany Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 29. Germany Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 31. France Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 33. U.K. Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 35. Italy Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 37. Russia Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region in 2019 Figure 39. Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region in 2019 Figure 40. China Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 41. China Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 43. Japan Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 45. South Korea Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 47. India Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 49. Australia Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 51. Taiwan Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 53. Indonesia Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 55. Thailand Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 57. Malaysia Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 59. Philippines Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 61. Vietnam Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country in 2019 Figure 63. Latin America Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country in 2019 Figure 64. Mexico Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 65. Mexico Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 67. Brazil Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 69. Argentina Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country in 2019 Figure 72. Turkey Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 73. Turkey Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 75. Saudi Arabia Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2020) (Kg) Figure 77. U.A.E Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Parecoxib Sodium (CAS 198470-85-8) by Type (2015-2020) Figure 79. Sales Market Share of Parecoxib Sodium (CAS 198470-85-8) by Type in 2019 Figure 80. Revenue Share of Parecoxib Sodium (CAS 198470-85-8) by Type (2015-2020) Figure 81. Revenue Market Share of Parecoxib Sodium (CAS 198470-85-8) by Type in 2019 Figure 82. Global Parecoxib Sodium (CAS 198470-85-8) Sales Growth by Type (2015-2020) (Kg) Figure 83. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020) Figure 84. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Parecoxib Sodium (CAS 198470-85-8) by Application (2015-2020) Figure 86. Global Revenue Share of Parecoxib Sodium (CAS 198470-85-8) by Application in 2020 Figure 87. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Sailong Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Chiarai Tianqing Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Qilu Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Kelun Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Price Trend of Key Raw Materials Figure 93. Manufacturing Cost Structure of Parecoxib Sodium (CAS 198470-85-8) Figure 94. Manufacturing Process Analysis of Parecoxib Sodium (CAS 198470-85-8) Figure 95. Parecoxib Sodium (CAS 198470-85-8) Industrial Chain Analysis Figure 96. Channels of Distribution Figure 97. Distributors Profiles Figure 98. Porter's Five Forces Analysis Figure 99. North America Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 100. North America Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 101. Europe Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 102. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Latin America Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 104. Latin America Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 106. Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 108. Asia Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Pfizer Sailong Pharma Chiarai Tianqing Qilu Pharma Kelun Pharma